Revance Therapeutics (RVNC) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free RVNC Stock Alerts $3.29 -0.28 (-7.84%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFinancial Contrast: Revance Therapeutics (NASDAQ:RVNC) vs. CymaBay Therapeutics (NASDAQ:CBAY)americanbankingnews.com - April 20 at 1:42 AMRevance Therapeutics, Inc. (NASDAQ:RVNC) Short Interest Up 24.7% in Marchmarketbeat.com - April 14 at 12:38 AMRevance Therapeutics, Inc. (NASDAQ:RVNC) is favoured by institutional owners who hold 63% of the companyfinance.yahoo.com - April 12 at 10:20 AMRevance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meetingbusinesswire.com - April 12 at 8:00 AMRevance Therapeutics (NASDAQ:RVNC) Stock Price Up 8.5%marketbeat.com - April 9 at 12:11 PMRevance Therapeutics, Inc. (NASDAQ:RVNC) Receives Consensus Recommendation of "Moderate Buy" from Analystsmarketbeat.com - April 1 at 4:30 AMRevance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - March 27 at 9:06 PMRevance Therapeutics (NASDAQ:RVNC) Trading Up 4%marketbeat.com - March 27 at 12:44 PMRevance Therapeutics, Inc. (NASDAQ:RVNC) Insider Dwight Moxie Sells 8,125 Sharesinsidertrades.com - March 20 at 7:32 AMRevance Therapeutics, Inc. (NASDAQ:RVNC) Insider Sells $40,950.00 in Stockmarketbeat.com - March 19 at 8:15 PMRVNC Apr 2024 5.000 putfinance.yahoo.com - March 16 at 3:39 PMRevance Therapeutics (NASDAQ:RVNC) Shares Down 3.8% marketbeat.com - March 12 at 12:53 PMRevance stock rises after CEO discloses share purchasemsn.com - March 11 at 8:31 AMLazard Asset Management LLC Has $885,000 Stock Position in Revance Therapeutics, Inc. (NASDAQ:RVNC)marketbeat.com - March 10 at 5:46 AMRevance Therapeutics, Inc. (NASDAQ:RVNC) Receives Average Rating of "Moderate Buy" from Brokeragesmarketbeat.com - March 7 at 3:52 AMRevance Therapeutics (NASDAQ:RVNC) Stock Price Up 7.7%marketbeat.com - March 5 at 3:17 PMRevance Prices Offering Of 16 Mln Shares At $6.25/Share; Stock Dropsmarkets.businessinsider.com - March 4 at 3:48 PMEULAV Asset Management Increases Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC)marketbeat.com - March 4 at 11:17 AMRevance Therapeutics Shares Slide After Public Offeringmarketwatch.com - March 4 at 10:48 AMRevance Proposes Public Offering Of $100 Mln Of Shares; Stock Down Over 8% In Pre-marketmarkets.businessinsider.com - March 4 at 10:48 AMRevance Therapeutics down 7%, prices $100M share offeringmsn.com - March 4 at 10:48 AMRevance Announces Pricing of $100.0 Million Public Offering of Common Stockfinance.yahoo.com - March 4 at 10:48 AMRevance Announces Proposed Public Offering of Common Stockbusinesswire.com - March 4 at 6:37 AMUS$16.33: That's What Analysts Think Revance Therapeutics, Inc. (NASDAQ:RVNC) Is Worth After Its Latest Resultsfinance.yahoo.com - March 2 at 10:23 AMRevance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 2 at 10:23 AMRevance Therapeutics Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - March 1 at 8:32 AMRevance Therapeutics (NASDAQ:RVNC) PT Raised to $9.00marketbeat.com - March 1 at 8:28 AMRevance: Stock Bouncing On Q4 Earnings, But Long-Term Challenges Remainseekingalpha.com - February 29 at 5:14 PMAnalysts Are Bullish on These Healthcare Stocks: Avidity Biosciences (RNA), Revance Therapeutics (RVNC)markets.businessinsider.com - February 29 at 12:57 PMNeedham & Company LLC Cuts Revance Therapeutics (NASDAQ:RVNC) Price Target to $18.00marketbeat.com - February 29 at 9:40 AMBamco Inc. NY Has $11.70 Million Stock Position in Revance Therapeutics, Inc. (NASDAQ:RVNC)marketbeat.com - February 29 at 8:24 AMQ4 2023 Revance Therapeutics Inc Earnings Callfinance.yahoo.com - February 29 at 7:57 AMRevance Therapeutics: Strategic Pivot and Growth Potential Justify Buy Ratingmarkets.businessinsider.com - February 29 at 2:56 AMRevance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Updatefinance.yahoo.com - February 28 at 8:47 PMRevance Therapeutics Inc (RVNC) Reports Strong Revenue Growth in Q4 and Full Year 2023finance.yahoo.com - February 28 at 8:47 PMEarnings Outlook For Revance Therapeuticsbenzinga.com - February 27 at 12:33 PMHC Wainwright Trims Revance Therapeutics (NASDAQ:RVNC) Target Price to $12.00marketbeat.com - February 23 at 10:17 AMRevance Therapeutics Stock (NASDAQ:RVNC), Short Interest Reportbenzinga.com - February 22 at 6:07 PMRevance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024finance.yahoo.com - February 21 at 8:42 AMRevance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024businesswire.com - February 21 at 8:01 AMRevance to Participate in Upcoming Investor Conferencesbusinesswire.com - February 21 at 8:00 AMHalozyme Therapeutics (HALO) Q4 Earnings Match Estimatesfinance.yahoo.com - February 20 at 6:26 PMRVNC Revance Therapeutics, Inc.seekingalpha.com - February 17 at 2:47 PMJump Financial LLC Trims Stock Position in Revance Therapeutics, Inc. (NASDAQ:RVNC)marketbeat.com - February 17 at 5:25 AMRevance Therapeutics, Inc. (NASDAQ:RVNC) Receives Consensus Rating of "Moderate Buy" from Brokeragesmarketbeat.com - February 11 at 3:32 AMRevance Therapeutics Sets Executive Compensation for 2024msn.com - February 7 at 9:40 AMRevance Therapeutics (NASDAQ:RVNC) Stock Price Up 12.5%marketbeat.com - February 6 at 2:25 PMAllspring Global Investments Holdings LLC Reduces Stake in Revance Therapeutics, Inc. (NASDAQ:RVNC)marketbeat.com - February 5 at 4:26 AMRevance jumps as Daxxify reimbursement simplified with permanent J-codemsn.com - February 3 at 7:38 AMPrincipal Financial Group Inc. Purchases 342,540 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC)marketbeat.com - February 3 at 4:25 AM Get Revance Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RVNC and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> RVNC Media Mentions By Week RVNC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RVNC News Sentiment▼0.500.41▲Average Medical News Sentiment RVNC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RVNC Articles This Week▼23▲RVNC Articles Average Week Get Revance Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RVNC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ANL News Today PEPG News Today NKTX News Today ORGO News Today LXRX News Today AMRN News Today STTK News Today TRDA News Today BMEA News Today ADCT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RVNC) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revance Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
